The electronization of healthcare (eHealth) streamlines processes in healthcare and improves the quality and availability of medical care. Some elements of eHealth already existed in Czech law, but the legislation was fragmented. To set the general framework, basic rules, and standards for the functioning of eHealth, a new Act No 325/2021 Coll., on electronization of healthcare (Act) was adopted, with effect from January 1, 2022.
Unstoppable Force Meets Immovable Object: Green Claims in Pharma
The ascendant popularity of ESG across business sectors has also empowered the rise of its evil twin: greenwashing. To look at the interplay between the two and their implications for the pharma industry in CEE, we sat down with CMS Partners Gabriela Staber and Tomas Matejovsky.
Landmark Decision of the Constitutional Court: Do You Need Information from the Health System?
If you need statistical data maintained by the National Health Information System for your work or scientific research, whether demographic data on births or deaths, statistics on cancer patients, information on assisted reproduction or other information, you will be interested in a landmark decision of the Constitutional Court.
NKO Partners Advises Dr. Max Group on Acquisition of Cvejic Pharmacy Chain
NKO Partners has advised the Dr. Max Group on its acquisition of the Cvejic pharmacy chain in Serbia. Bajic & Popovic reportedly advised the seller.
Gabor Kukovecz Joins Phoenix Hungary as Group Legal Director
Former Diageo Head of Legal & Operations and DPO Gabor Kukovecz has joined the Phoenix Group in Hungary as the Group Legal Director.
Wardynski & Partners Advise CNS Pharmaceuticals on Berubicin Supply Agreement with Pomeranian Medical University
Wardynski & Partners has advised CNS Pharmaceuticals on negotiating a contract to supply Berubicin to the Pomeranian Medical University.
Deal 5: Croma Pharma Managing Director Andreas Prinz on Combination Agreement with EHC Business
On January 4, CEE Legal Matters reported that Dorda, working with Loyens & Loeff, had advised Croma-Pharma on entering into a business combination agreement with the European Healthcare Acquisition & Growth Company. CEE In-House Matters spoke with Andreas Prinz, Managing Director at Croma Pharma, to learn more about the deal.